Heike Schauerte,Hans Allgeier,Michael A. Pleiss,Martin Augustin,Gisela Peraus,Gabriele Stumm,Philipp Wabnitz
申请号：
US12451040
公开号：
US08389521B2
申请日:
2008.04.24
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).
